CBDG logo

THC Farmaceuticals, Inc. (CBDG) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CBDG steht fuer THC Farmaceuticals, Inc., ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 42/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 15. März 2026
42/100 KI-Bewertung

THC Farmaceuticals, Inc. (CBDG) Gesundheitswesen & Pipeline-Uebersicht

CEOEd Rosenthal
HauptsitzScottsdale, US
IPO-Jahr2014

THC Farmaceuticals, Inc. (CBDG) operates a limited number of cash-dispensing ATMs in Utah, targeting small and medium-sized businesses in high-traffic areas. Formerly City Media, the company's current focus is on ATM services, distinguishing it from biotechnology peers despite its industry classification.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 15. März 2026

Investmentthese

THC Farmaceuticals, Inc. (CBDG) presents a speculative investment opportunity due to its limited operations and OTC market listing. The company's small ATM network in Utah generates revenue from transaction fees, but its financial viability is uncertain given the limited scale. Growth catalysts depend on expanding the ATM network and increasing transaction volume. Key risks include limited capital, competition from established ATM operators, and regulatory challenges associated with the OTC market. The company's negative P/E ratio of -55.69 and a beta of -9.64 reflect its volatile financial performance and market sensitivity.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Operates a small network of eight ATMs in Utah as of June 30, 2015.
  • Formerly known as City Media, Inc., changed its name to THC Farmaceuticals, Inc. in February 2015.
  • Subsidiary of Weed Growth Fund, Inc.
  • Targets small and medium-sized businesses in high-traffic areas.
  • P/E ratio of -55.69 indicates negative earnings.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Established ATM network in Utah.
  • Relationships with local businesses.
  • Convenient ATM locations.
  • Subsidiary of Weed Growth Fund, Inc.

Schwaechen

  • Limited geographic scope.
  • Small ATM network.
  • Dependence on transaction fees.
  • Negative P/E ratio.

Katalysatoren

  • Ongoing: Expansion of ATM network into new locations.
  • Ongoing: Strategic partnerships with local businesses.
  • Upcoming: Technological upgrades to existing ATMs.
  • Upcoming: Implementation of targeted marketing campaigns.
  • Upcoming: Diversification of services offered through ATMs.

Risiken

  • Potential: Increased competition from larger ATM networks.
  • Potential: Shift towards digital payment solutions.
  • Potential: Regulatory changes affecting ATM operations.
  • Potential: Economic downturn impacting transaction volume.
  • Ongoing: Limited financial disclosure and liquidity.

Wachstumschancen

  • Expansion of ATM Network: THC Farmaceuticals can grow by expanding its ATM network within Utah and potentially into neighboring states. Identifying strategic locations with high foot traffic and limited ATM access is crucial. The market for ATM services in underserved areas presents an opportunity to increase transaction volume and revenue, although this requires capital investment and operational expertise.
  • Strategic Partnerships: Forming partnerships with local businesses and event organizers can increase ATM visibility and usage. Offering exclusive deals or discounts to customers who use THC Farmaceuticals' ATMs can incentivize transactions. These partnerships can create a mutually beneficial ecosystem, driving revenue for both the company and its partners.
  • Technological Upgrades: Upgrading existing ATMs with advanced features such as contactless payment options and mobile wallet integration can attract a wider customer base. Investing in secure and reliable ATM technology is essential for maintaining customer trust and preventing fraud. These upgrades can enhance the user experience and increase transaction volume.
  • Targeted Marketing Campaigns: Implementing targeted marketing campaigns to promote the convenience and accessibility of THC Farmaceuticals' ATMs can drive customer awareness and usage. Utilizing social media, local advertising, and in-store promotions can effectively reach the target audience. These campaigns should highlight the benefits of using ATMs for cash transactions.
  • Diversification of Services: Exploring opportunities to offer additional services through its ATM network, such as bill payment and prepaid card loading, can generate new revenue streams. Partnering with service providers to offer these value-added services can enhance the attractiveness of THC Farmaceuticals' ATMs. This diversification can increase customer engagement and loyalty.

Chancen

  • Expansion into new locations.
  • Strategic partnerships.
  • Technological upgrades.
  • Diversification of services.

Risiken

  • Competition from larger ATM networks.
  • Increasing use of digital payment solutions.
  • Regulatory changes.
  • Economic downturn.

Wettbewerbsvorteile

  • Limited geographic focus in Utah.
  • Established relationships with local businesses.
  • Convenient ATM locations in high-traffic areas.

Ueber CBDG

Founded in 2008 and based in Scottsdale, Arizona, THC Farmaceuticals, Inc., formerly known as City Media, Inc., transitioned to its current name in February 2015. The company operates as a subsidiary of Weed Growth Fund, Inc. Its primary business involves owning and operating non-financial institution cash-dispensing automated teller machines (ATMs) at third-party owned retail and commercial locations. These ATMs are strategically placed in locations such as hotels, stores, and bowling alleys, targeting small and medium-sized businesses with high customer traffic. As of June 30, 2015, THC Farmaceuticals had a total of eight ATMs in operation along the Wasatch Front in the State of Utah. The company's operations are limited geographically and in scale, focusing on providing convenient cash access in specific locales.

Was das Unternehmen tut

  • Owns and operates cash-dispensing ATMs.
  • Places ATMs in third-party retail and commercial locations.
  • Targets hotels, stores, and bowling alleys.
  • Focuses on small and medium-sized businesses.
  • Provides cash access in high-traffic areas.
  • Operates in the State of Utah.

Geschaeftsmodell

  • Generates revenue from transaction fees charged to ATM users.
  • Partners with retail and commercial locations to host ATMs.
  • Maintains and services its ATM network.

Branchenkontext

THC Farmaceuticals, Inc. operates within the broader financial services industry, specifically in the niche market of non-bank ATM operations. The ATM market is characterized by established players and increasing competition from digital payment solutions. While the overall ATM market is mature, opportunities exist for smaller operators to serve niche markets and specific geographic areas. THC Farmaceuticals' limited scale and focus on the Utah market position it as a micro-player within this landscape, facing competition from larger ATM networks and evolving payment technologies.

Wichtige Kunden

  • Retail customers needing cash access.
  • Small and medium-sized businesses hosting ATMs.
  • Tourists and visitors requiring cash transactions.
KI-Zuversicht: 69% Aktualisiert: 15. März 2026

Finanzdaten

Chart & Info

THC Farmaceuticals, Inc. (CBDG) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer CBDG verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CBDG.

Kursziele

Wall-Street-Kurszielanalyse fuer CBDG.

MoonshotScore

42/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von CBDG auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Ed Rosenthal

CEO

Information on Ed Rosenthal's background is not available in the provided data. Further research would be needed to determine his career history, education, and previous roles. Without this information, a comprehensive profile cannot be created.

Erfolgsbilanz: Information on Ed Rosenthal's track record is not available in the provided data. Further research would be needed to determine his key achievements, strategic decisions, and company milestones under his leadership. Without this information, a comprehensive assessment cannot be provided.

CBDG OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that THC Farmaceuticals, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial information available and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited liquidity and transparency.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for THC Farmaceuticals, Inc. (CBDG) is likely very limited given its OTC Other listing. This typically translates to low trading volume, potentially wide bid-ask spreads, and difficulty in executing large trades without significantly impacting the price. Investors should be prepared for potential challenges in buying or selling shares quickly and at desired prices.
OTC-Risikofaktoren:
  • Limited financial disclosure.
  • Low trading volume and liquidity.
  • Potential for price manipulation.
  • Higher risk of fraud or scams.
  • Limited regulatory oversight.
Sorgfaltspruefung-Checkliste:
  • Verify the company's registration and legal status.
  • Review available financial statements and disclosures.
  • Assess the company's business model and revenue streams.
  • Research the company's management team and their track record.
  • Evaluate the company's competitive landscape and market position.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor.
Legitimitaetssignale:
  • Subsidiary of Weed Growth Fund, Inc.
  • Operational ATM network in Utah.
  • Established business since 2008.

Haeufige Fragen zu CBDG

What are the key factors to evaluate for CBDG?

THC Farmaceuticals, Inc. (CBDG) currently holds an AI score of 42/100, indicating low score. Key strength: Established ATM network in Utah.. Primary risk to monitor: Potential: Increased competition from larger ATM networks.. This is not financial advice.

How frequently does CBDG data refresh on this page?

CBDG prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CBDG's recent stock price performance?

Recent price movement in THC Farmaceuticals, Inc. (CBDG) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established ATM network in Utah.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CBDG overvalued or undervalued right now?

Determining whether THC Farmaceuticals, Inc. (CBDG) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CBDG?

Before investing in THC Farmaceuticals, Inc. (CBDG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CBDG to a portfolio?

Potential reasons to consider THC Farmaceuticals, Inc. (CBDG) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Established ATM network in Utah.. Additionally: Relationships with local businesses.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CBDG?

Yes, most major brokerages offer fractional shares of THC Farmaceuticals, Inc. (CBDG) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CBDG's earnings and financial reports?

THC Farmaceuticals, Inc. (CBDG) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CBDG earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited information available on THC Farmaceuticals, Inc.
  • OTC market carries higher risks.
  • Financial data is limited.
Datenquellen

Popular Stocks